|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
ATE317435T1
(de)
|
1995-02-24 |
2006-02-15 |
Sloan Kettering Inst Cancer |
Prostataspezifisches membranes antigen und seine anwendungen
|
|
US6962981B1
(en)
|
1996-03-25 |
2005-11-08 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6150508A
(en)
*
|
1996-03-25 |
2000-11-21 |
Northwest Biotherapeutics, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US7381407B1
(en)
|
1996-03-25 |
2008-06-03 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6107090A
(en)
|
1996-05-06 |
2000-08-22 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
|
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
|
GB2328871A
(en)
*
|
1997-09-05 |
1999-03-10 |
Merck & Co Inc |
Compositions for inhibiting platelet aggregation
|
|
AU3305699A
(en)
*
|
1998-02-26 |
1999-09-15 |
Beckman Coulter, Inc. |
Prostate-specific membrane antigens and methods of making and using
|
|
CA2328989C
(en)
*
|
1998-06-01 |
2012-02-07 |
Urogenesys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20030035798A1
(en)
*
|
2000-08-16 |
2003-02-20 |
Fang Fang |
Humanized antibodies
|
|
SE9900495D0
(sv)
*
|
1999-02-12 |
1999-02-12 |
Pharmatrix Ab |
Vaccine composition
|
|
WO2000050457A1
(en)
*
|
1999-02-22 |
2000-08-31 |
Beckman Coulter, Inc. |
Prostate-specific membrane antigens and methods of making and using
|
|
EP1710256A1
(en)
*
|
1999-07-29 |
2006-10-11 |
Medarex, Inc. |
Human monoclonal antibodies to prostate specific membrane antigen
|
|
MXPA02000961A
(es)
*
|
1999-07-29 |
2003-08-20 |
Medarex Inc |
Anticuerpos monoclonales humanos para antigeno de membrana especifico de la prostata.
|
|
FR2797743B1
(fr)
*
|
1999-08-23 |
2003-08-08 |
Urogene |
Lignee cellulaire prostatique et son utilisation pour l'obtention d'une tumeur prostatique etablie chez l'animal
|
|
AU7351800A
(en)
*
|
1999-09-13 |
2001-04-17 |
Neil H. Bander |
A method for isolation of prostatic epithelial cells from semen
|
|
JP4838436B2
(ja)
*
|
2001-04-04 |
2011-12-14 |
積水メディカル株式会社 |
抗ヒト肝性トリグリセリドリパーゼ抗体
|
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
MXPA03010804A
(es)
|
2001-06-01 |
2004-11-22 |
Cornell Res Foundation Inc |
Anticuerpos modificados para antigeno de membrana especifico de la prostata y usos de los mismos.
|
|
AU2002305767B2
(en)
|
2001-09-20 |
2008-04-10 |
Cornell Research Foundation, Inc. |
Methods and compositions for treating and preventing skin disorders using binding agents specific for PSMA
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
EP1448588A4
(en)
|
2001-10-23 |
2006-10-25 |
Psma Dev Company L L C |
ANTIBODIES AND MULTIMERS OF PSMA PROTEINS
|
|
US20040161776A1
(en)
*
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
US7771953B2
(en)
|
2003-01-10 |
2010-08-10 |
Millenium Pharmaceuticals, Inc. |
Methods of diagnosing and treating cancer
|
|
CN101160324B
(zh)
|
2005-02-18 |
2013-04-24 |
米德列斯公司 |
缺乏岩藻糖残基的抗前列腺特异性膜抗原(psma)单克隆抗体
|
|
WO2006105488A2
(en)
*
|
2005-03-31 |
2006-10-05 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161p2f10b proteins
|
|
EP1726650A1
(en)
|
2005-05-27 |
2006-11-29 |
Universitätsklinikum Freiburg |
Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
|
|
CA2623236A1
(en)
|
2005-09-26 |
2007-04-05 |
Medarex, Inc. |
Human monoclonal antibodies to cd70
|
|
EP1996716B1
(en)
|
2006-03-20 |
2011-05-11 |
The Regents of the University of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
|
US8940298B2
(en)
|
2007-09-04 |
2015-01-27 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
|
|
JP5286370B2
(ja)
|
2008-02-29 |
2013-09-11 |
アイメック |
細胞酵素ベースのバイオセンサ
|
|
WO2010027513A2
(en)
|
2008-09-08 |
2010-03-11 |
Psma Development Company, Llc |
Methods for killing psma-expressing, taxane-resistant cancer cells
|
|
JP5906090B2
(ja)
|
2009-02-17 |
2016-04-20 |
コーネル・リサーチ・ファンデーション・インコーポレイテッドＣｏｒｎｅｌｌ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ， Ｉｎｃｏｒｐｏｒａｔｅｄ |
癌の診断のための方法およびキットならびに治療価の推定
|
|
US8772459B2
(en)
|
2009-12-02 |
2014-07-08 |
Imaginab, Inc. |
J591 minibodies and Cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their use
|
|
JP6088488B2
(ja)
|
2011-04-21 |
2017-03-01 |
シアトル ジェネティックス， インコーポレイテッド |
新規な結合剤−薬物複合体（ａｄｃ）およびそれらの使用
|
|
BR112013027224A8
(pt)
|
2011-04-22 |
2018-08-14 |
Emergent Product Dev Seattle |
Proteínas de ligação de antígeno de membrana específico de próstata e composições e métodos relacionados
|
|
US10022453B2
(en)
|
2013-12-23 |
2018-07-17 |
Bayer Pharma Aktiengesellschaft |
Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
|
|
EP4406606A3
(de)
|
2015-06-22 |
2024-10-09 |
Bayer Pharma Aktiengesellschaft |
Binder-wirkstoff-konjugate (adcs) und binder-prodrug-konjugate (apdcs) mit enzymatisch spaltbaren g
|
|
JOP20160154B1
(ar)
*
|
2015-07-31 |
2021-08-17 |
Regeneron Pharma |
أجسام ضادة مضاد لل psma، وجزيئات رابطة لمستضد ثنائي النوعية الذي يربط psma و cd3، واستخداماتها
|
|
MX2018001566A
(es)
|
2015-08-07 |
2019-04-25 |
Imaginab Inc |
Construcciones de union a antigeno para moleculas diana.
|
|
US11352426B2
(en)
|
2015-09-21 |
2022-06-07 |
Aptevo Research And Development Llc |
CD3 binding polypeptides
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
CN116059390A
(zh)
|
2016-03-24 |
2023-05-05 |
拜耳制药股份公司 |
具有酶促可裂解基团的细胞毒性活性物质的前药
|
|
US11001636B2
(en)
|
2016-06-15 |
2021-05-11 |
Bayer Pharma Aktiengesellschaft |
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies
|
|
CN110072556B
(zh)
|
2016-12-21 |
2023-05-02 |
拜耳制药股份公司 |
具有ksp抑制剂的特异性抗体药物缀合物(adc)
|
|
MX2019007641A
(es)
|
2016-12-21 |
2019-09-09 |
Bayer Pharma AG |
Conjugados de ligando-farmaco (adcs) con grupos escindibles enzimaticamente.
|
|
CN110312533B
(zh)
|
2016-12-21 |
2023-11-03 |
拜耳公司 |
具有酶促可裂解的基团的细胞毒性活性剂的前药
|
|
JP7526097B2
(ja)
|
2018-03-06 |
2024-07-31 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
前立腺特異的膜抗原ｃａｒおよびその使用方法
|
|
CN112469440B
(zh)
*
|
2018-06-18 |
2024-09-06 |
优瑞科生物技术公司 |
靶向前列腺特异性膜抗原(psma)的构建体和其用途
|
|
JP7586399B2
(ja)
|
2018-07-31 |
2024-11-19 |
ハイデルベルク ファルマ リサーチ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｐｓｍａに対するヒト化抗体
|